March 23, 2017
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 4546
Washington, D.C. 20549
| Attn: | Suzanne Hayes |
| Re: | Cara Therapeutics, Inc. |
Registration Statement on Form S-3
File No. 333-216657
Acceleration Request
| Requested Date: | Friday, March 24, 2017 |
| Requested Time: | 4:00 P.M. Eastern Daylight Time |
Dear Ms. Hayes:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-216657) (the “Registration Statement”) to become effective on March 24, 2017, at 4:00 p.m. Eastern Daylight Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Darren DeStefano of Cooley LLP, counsel to the Registrant, at (703) 456-8034, or in his absence, Alison Haggerty at (212) 479-6596.
| Very truly yours, | ||
| Cara Therapeutics, Inc. | ||
| By: |
/s/ Josef Schoell | |
|
| ||
| Josef Schoell | ||
| Chief Financial Officer | ||
| cc: | Derek Chalmers, Ph.D., D.Sc., Cara Therapeutics, Inc. |
Darren K. DeStefano, Cooley LLP
Alison A. Haggerty, Cooley LLP